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Abstract
Background: Recently research has shown that larviciding can be an effective tool for integrated malaria vector
control. Nevertheless, the uptake of this intervention has been hampered by the need to re-apply larvicides
frequently. There is a need to explore persistent, environmentally friendly larvicides for malaria vector control to
reduce intervention efforts and costs by reducing the frequency of application. In this study, the efficacy of a 0.5%
pyriproxyfen granule (SurmilarvW0.5G, Sumitomo Chemicals) was assessed for the control of Anopheles gambiae
sensu stricto and Anopheles arabiensis, the major malaria vectors in sub-Saharan Africa.
Methods: Dose–response and standardized field tests were implemented following standard procedures of the
World Health Organization’s Pesticide Evaluation Scheme to determine: (i) the susceptibility of vectors to this
formulation; (ii) the residual activity and appropriate retreatment schedule for field application; and, (iii) sub-lethal
impacts on the number and viability of eggs laid by adults after exposure to SumilarvW0.5G during larval
development.
Results: Anopheles gambiae s.s. and An. arabiensis were highly susceptible to SumilarvW0.5G. Estimated emergence
inhibition (EI) values were very low and similar for both species. The minimum dosage that completely inhibited
adult emergence was between 0.01-0.03 parts per million (ppm) active ingredient (ai). Compared to the untreated
control, an application of 0.018 ppm ai prevented 85% (95% confidence interval (CI) 82%-88%) of adult emergence
over six weeks under standardized field conditions. A fivefold increase in dosage of 0.09 ppm ai prevented 97%
(95% CI 94%-98%) emergence. Significant sub-lethal effects were observed in the standardized field tests. Female
An. gambiae s.s. that were exposed to 0.018 ppm ai as larvae laid 47% less eggs, and females exposed to 0.09 ppm
ai laid 74% less eggs than females that were unexposed to the treatment. Furthermore, 77% of eggs laid by
females exposed to 0.018 ppm ai failed to hatch, whilst 98% of eggs laid by females exposed to 0.09 ppm ai did
not hatch.
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Conclusion: Anopheles gambiae s.s. and An. arabiensis are highly susceptible to SumilarvW0.5G at very low dosages.
The persistence of this granule formulation in treated habitats under standardized field conditions and its sub-lethal
impact, reducing the number of viable eggs from adults emerging from treated ponds, enhances its potential as
malaria vector control tool. These unique properties warrant further field testing to determine its suitability for
inclusion in malaria vector control programmes.
Keywords: Pyriproxyfen, SumilarvW0.5G, Malaria, Larval source management, Anopheles gambiae s.s., Anopheles
arabiensis
Background
Malaria control interventions with long-lasting insecticidal
nets (LLINs) and indoor residual spraying (IRS) have
resulted in substantial reductions of malaria cases in sub-
Saharan Africa [1,2]. Since both LLINs and IRS target the
fraction of the vector population that enter houses [3,4]
their efficacy is threatened by vectors developing resist-
ance to insecticides used indoors [5-7] and behavioural
adaptations where vectors shift their biting patterns to bite
in early evening and in the morning when people are out
of the nets [8,9]. There has also been a shift in the vector
species’ composition in parts of East Africa with LLINs
dramatically reducing the numbers of largely endophilic
Anopheles gambiae s.s. but having little or no impact on
Anopheles arabiensis that tends to bite and rest outdoors
[10-13] resulting in An. arabiensis becoming the dominant
vector. Since IRS and LLINs cannot totally suppress mal-
aria transmission there is a growing interest in the use of
additional tools in an integrated vector management ap-
proach [14-18].
Larval source management has been re-evaluated for
malaria control [19-24], with results indicating the added
benefit larval control could have when used together with
interventions that target adult mosquitoes [14,15,25]. One
of the advantages of larval source management is that it tar-
gets the aquatic stages of the vectors thus controlling both
indoor and outdoor biting and resting and insecticide re-
sistant mosquitoes [26]. Commercially available chemical
larvicides and microbials are highly effective in the control
of the major malaria vectors of sub-Saharan Africa
[20,24,27-33]. However, relatively few studies evaluated
them under operational conditions [15,23,34-37] and a
major limitation is their short activity under most environ-
mental conditions, frequently requiring weekly re-
application [20,21,34,38]. Larvicide and labour are the
major costs in large-scale larval control programmes and
these could be substantially reduced if re-application inter-
vals could be reduced without jeopardizing the impact of
the intervention [39]. In addition, the toxic effects of
chemical-based larvicides to non-target aquatic insects
limits their use for regular larviciding programmes [40,41].
SumilarvW0.5G (Sumitomo Chemicals) is a granule in-
secticide developed for mosquito control. The active in-
gredient is pyriproxyfen (4-phenoxyphenyl (RS)-2-(2-
pyridyloxy) propyl ether), a juvenile hormone analogue
that acts as an insect growth regulator [42]. Pyriproxyfen
generally inhibits adult emergence of target insects
[43-45]. However it also has delayed effects on female
reproduction of adult mosquitoes exposed to sub-lethal
doses at the larval [46,47] or adult stage [48,49].
SumilarvW0.5 has exceptional residual activity of up to six
months for the control of Aedes, Culex and Anopheles
mosquitoes in their natural breeding habitats [44,45,49,50].
Furthermore, pyriproxyfen has been evaluated as a
safe insecticide for application in drinking water [51]
with minimal impacts on non-target aquatic insects
and the environment [52-56]. Nevertheless, SumilarvW0.5G
has never been evaluated for the control of immature
stages of An. gambiae s.l., the major malaria vector in
sub-Saharan Africa.
The objectives of the present study were to evaluate the
efficacy of this granular formulation of pyriproxyfen
for the control of An. arabiensis and An. gambiae s.s.
by determining: (i) the minimum effective dose in
dose–response tests; (ii) the optimum application dose
to be applied under field conditions; (iii) the residual period
of the optimum dose; and, (iv) the effects of sub-lethal
doses on egg production and larval hatching. All tests
were based on the World Health Organization Pesticide
Evaluation Scheme (WHOPES) guidelines for laboratory
and field testing of mosquito larvicides [57].
Methods
Study area
The study was conducted at the International Centre of
Insect Physiology and Ecology-Thomas Odhiambo Campus
(icipe-TOC) in Mbita (0° 26΄ 06.19” S; 34° 12΄ 53.13” E)
close to Lake Victoria, Western Kenya (altitude 1,137 m).
Here, the major malaria vectors are An. arabiensis with a
small number of An. gambiae s.s. and Anopheles funestus
[58]. The area is characterized by a tropical climate
with an average annual minimum temperature of
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16°C and an average maximum temperature of 28°C
(icipe-TOC meteorological station data for 2010 to
2012). The area experiences two major rainy seasons,
the long rains between March and June and the short
rains between October and December. The average
annual rainfall for 2010 to 2012 was 1,150 mm (icipe-TOC
meteorological station).
Mosquitoes
Both laboratory and standardized field tests used insectary-
reared third instar larvae of An. arabiensis and An. gambiae
s.s. (Mbita strains). Larvae were reared in round plastic tubs
(diameter 60 cm) filled with water (5 l, 5 cm high) from
Lake Victoria filtered through a charcoal-sand filter.
Mosquito larvae were fed with fish food (Tetramin©Baby)
twice daily. Third instar mosquito larvae were selected
from different tubs so that the larvae were of a simi-
lar range in size in each tub tested [59]. Mosquito
larvae were reared at ambient climate and light con-
ditions in a netting-screened greenhouse with an
average daily temperature of 27°C, an average 76%
relative humidity and a natural 12 hours of dark and
12 hours of light cycle.
Insecticide
SumilarvW0.5G was provided by the manufacturer
Sumitomo Chemicals Company, Japan, for all tests. It is
a granular formulation containing 0.5% active ingredient
(weight: weight).
Dose–response tests
Tests were done in the shade, under ambient climate
and light conditions in a netting-screened greenhouse.
Prior to the dose–response tests, range-finding tests
were implemented by exposing test larvae to a wide
range of test concentrations and a control. This served
to find the activity range of the insecticide for each test
species. Concentrations between 10 parts per million
(ppm) active ingredient (ai) and 0.0000001 ppm ai were
tested. After determining the emergence inhibition (EI)
of the larvae in the wider range, nine concentrations
were chosen, yielding between 10% and 95% EI in
the range-finding tests in order to determine the
EI50, EI90 and EI99 in dose response bioassays. The
following concentrations were tested: 0.005 ppm ai,
0.001 ppm ai, 0.0005 ppm ai, 0.0001 ppm ai, 0.00007 ppm
ai, 0.00004 ppm ai and 0.00001 ppm ai, 0.000005 ppm ai,
0.000001 ppm ai.
A stock solution was prepared by grinding the granu-
lar formulation into a very fine powder following the
procedure of Sihuincha and others [49]. Using a pestle
and mortar, 5 g of SumilarvW0.5G (25 mg ai) was ground
and added to 500 ml of non-chlorinated tap water. This
gave a stock solution of 10,000 ppm SumilarvW0.5G
(50 ppm ai). The mouth of the vial was covered with
aluminium foil and the solution left to agitate for one
hour on a shaker. Since SumilarvW0.5G is a slow release
formulation the mixture was left overnight to allow the
active ingredient to be released into solution. In the
morning the mixture was again agitated on a shaker for
30 minutes to prepare a homogenous mixture since
some of the inert ingredients of the formulation (poten-
tially still containing some active ingredient) had settled
overnight. Serial dilutions were made immediately after
shaking in non-chlorinated tap water to produce the test
concentrations.
Anopheles arabiensis and An. gambiae s.s. were evalu-
ated in parallel. Each test concentration and a control
were replicated four times per round per mosquito spe-
cies. Two hundred ml of each test solution was set up in
300 ml plastic cups. Three rounds of tests were
implemented. Separate batches of 25 insectary-reared
third instar larvae of both test species were introduced
into each test concentration and the control (non-chlori-
nated tap water). Thus in total 300 larvae of each species
were tested per test concentration and control (total of
3000 larvae). Larvae were fed with Tetramin© Baby fish
food every 24 hours and cups covered with netting to
prevent any emerging adults from escaping. The number
of live and dead larvae, pupae and adults was recorded
every 24 hours for 10 days. Live pupae from each cup
were transferred into a separate cup with approximately
20 ml of water from the respective cup of collection.
These cups were covered with netting and pupae
monitored for emergence. Separate pipettes were used
to collect pupae from treated and control cups to
avoid cross-contamination.
Standardized field tests
Standardized field tests [57] were carried out in an open
field with grass approximately 3 cm in height between
October 2011 and March 2012. Thirty artificial ponds were
set up in an open field by sinking enamel-coated bowls
(diameter 42 cm, depth 10 cm) into the ground (Figure 1A).
Ponds were arranged 2 m apart in six rows. Each bowl was
filled with 8 l of non-chlorinated tap water. Into each pond
2 l of soil collected from the surrounding field was added
and mixed well to resemble a natural habitat. Batches of 50
insectary-reared third instar larvae were introduced into
each pond. SumilarvW0.5G treatment was applied after
introduction of larvae. Treatment of the ponds was allo-
cated randomly using a lottery system. In each treatment
round, 10 of the ponds served as untreated controls; in five
of them An. arabiensis were introduced and in the
other five An. gambiae s.s. Two application rates of
SumilarvW0.5G were tested per mosquito species. The ap-
plication rate was based on the surface area of the water,
which was 0.14 m2 per pond. SumilarvW0.5G was spread
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evenly over the entire water surface by hand. Five ponds
were treated with 1 mg ai per m2 (equalling 0.018 ppm ai
considering the volume of 8 l of water) while five other
ponds were treated with 5 mg ai per m2 (or 0.09 ppm ai)
per mosquito species. A netting-covered emergence trap
was placed on top of each pond to prevent wild mosqui-
toes from laying eggs in the sites and to prevent the escape
of any emerging adult mosquitoes (Figure 1B). The residual
activity of SumilarvW0.5G was evaluated by introducing
new batches of 50 insectary-reared third instar larvae into
each pond at weekly intervals. After one week all the larvae
had either emerged as adults or died. The efficacy of
SumilarvW0.5G was evaluated for six weeks. This experi-
ment was implemented three times (referred to as rounds
in the analyses).
To assess larval mortality, the number of larvae
present in each habitat was counted daily. First, the
emergence trap over each pond was assessed for the
presence of any newly emerged adults and any adults
collected with an aspirator and placed into a disposable
cup covered with netting. Any pupae in the ponds were
transferred into plastic cups holding 50 ml of the water
from the respective pond. Pupae collections were done
in the morning and evening so that any emergence or
emergence inhibition could be recorded daily in the
laboratory.
To monitor environmental parameters that may influ-
ence the efficacy of the insecticide, daily data on turbid-
ity and pH of water in each pond was collected. Ponds
were visually categorized into clear (ground visible) or
turbid ponds. The water pH was measured using a pH
meter (Phywe International, Germany).
Sub-lethal effects
Tests to assess the impact of sub-lethal doses of
SumilarvW0.5G were carried out under ambient condi-
tions in a netting-screened greenhouse. The number of
eggs laid and the number of eggs hatched (number of
offspring produced) per adult mosquito that emerged
from treated ponds were compared to that of the adults
that emerged from the untreated ponds in standardized
field tests. All pupae used in these tests were collected
from the ponds in week six of each test round. Emerged
adults were maintained with 6% glucose solution ad
libitum. When the adults were two to four days old they
were blood-fed twice on a human arm on two successive
days. A single gravid mosquito was introduced into each
cage with an oviposition cup (diameter = 7 cm) con-
taining 100 ml of non-chlorinated tap water. The num-
ber of eggs laid by each mosquito overnight and the
number of eggs hatched over one week were counted.
Sub-lethal effects of the treatment dosage of 1 mg ai
per m2 were tested with 20 individual females per round
of semi-field test for An. arabiensis and An. gambiae s.s.,
respectively (total 3 × 20 = 60 females per species). Due
to the persistent high immature mortality of the 5 mg ai
per m2 treatment only 10 females per species and round
could be tested (total 3 × 10 = 30 females per species).
Statistical analyses
Data analyses were done with SPSS statistical software
version 19. All data from the replicates of the dose–
response tests were pooled by doses for each mosquito
species for the estimation of the EI50, EI90 and EI99 values
using the log dosage-probit regression analysis with the
test dosages as covariates and species as factors in the
model. Relative median potency estimates were used to
compare the susceptibility of the two species. Generalized
estimating equations (GEE) were used to estimate the
overall emergence inhibition of the two SumilarvW0.5G
dosages for the six weeks treatment period in stan-
dardized field tests. The number of successful emerged
adults was the dependent variable and was fitted to a
negative binomial distribution with a log-link function
Figure 1 Set-up of standardized field test. (A) Enamel-coated bowl sunk into the ground and filled with water and soil to simulate a natural
pond. (B) Netting-covered emergence trap on top of a pond to prevent escape of emerged adults.
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and an exchangeable correlation matrix. The treatments,
test rounds, mosquito species, water turbidity (clear, tur-
bid), water pH (grouped in two categories: pH < 8, pH ≥8)
and the occurrence of rain during the test week (no rain,
rain) were added to the model as fixed factors. Since the
same pond was evaluated repeatedly for larval mortality
over the six-week period, the unique pond ID was in-
cluded as the repeated measures variable. Interaction
terms were included in the model between treatments and
turbidity, treatments and pH, and treatments and rain.
GEE models were also used to estimate the impact of
sub-lethal concentrations on the number of eggs laid
and the number of eggs that hatched from emerged
An. gambiae s.s. adults. The parameter estimates of
the GEE models were used to calculate the weekly
mean adult emergence, mean number of eggs laid per
female and mean number of laid eggs that hatched
into larvae and the associated 95% confidence inter-
vals (CIs) by removing the intercept from the models.
For the calculation of percent reduction the weekly
emergence inhibition in the treated ponds was corrected
using Abbott’s formula based on emergence in the
untreated ponds as denominator [60]. Percent reduction
was therefore calculated as follows:
% treatment EI ¼ % untreated EI % treated EI½   100%
% untreated EI
Results
Dose–response tests
The dose–response tests showed that SumilarvW0.5G af-
fected adult mosquito emergence in An. arabiensis and
An. gambiae s.s. at very low and over a very wide range
of concentrations (0.000001-0.005 ppm ai). Data from
the three rounds of dose–response tests showed similar
trends in emergence inhibition for each species and
were, therefore, pooled per dose (Figure 2) to estimate
emergence inhibition (EI) rates; EI 50, EI90 and EI99
(Table 1). The minimum dosage that completely inhi-
bited adult emergence was estimated to be between
0.01-0.03 ppm ai (Table 1). Anopheles arabiensis and An.
gambiae s.s. were equally susceptible to SumilarvW0.5G.
Standardized field tests
There was no difference in adult emergence from treated
ponds between An. arabiensis and An. gambiae s.s.
(p=0.3) and data for both species were pooled for ana-
lysis. The weekly adult emergence per round from the
treated and untreated ponds is shown in Figure 3 and
emergence inhibition calculated in Table 2. Complete
emergence inhibition was observed for two weeks in
rounds one and three of the high treatment dose of 5 mg
ai per m2 (0.09 ppm ai). However at the lower dosage of
1 mg ai per m2 (0.018 ppm ai) which corresponded
with the minimum effective dosage established in the
dose–response tests complete emergence inhibition was
only observed in week one in round one and three. Ponds
treated at 5 mg ai per m2 provided better residual impact
than the lower treatment dosage of 1 mg ai per m2
(Figure 3 and Table 2). Adjusting for other factors the
GEE model estimated that SumilarvW0.5G inhibited 85%
of adult emergence over a period of six weeks at an appli-
cation dose of 1 mg ai per m2 and 97% at a dose of 5 mg
ai per m2 compared to emergence from untreated ponds
(Table 3). The overall impact of 5 mg ai per m2 on
inhibiting emergence was significantly higher than the
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impact of 1 mg ai per m2 (p<0.001). Despite consistent
rainfall during the first round of the standardized field
tests and occasional rainfall during the following two
rounds (Figure 4), rain did neither affect the emergence of
adults from control and treatment ponds nor the impact
of the treatments (Table 3). There were also no main
effects of water turbidity or pH on adult emergence but
interactions were identified between the treatments and
water turbidity, and the treatments and water pH. Turbid
water and high pH reduced the impact of the treatments
leading to slightly higher adult emergence from treatment
ponds under these conditions (Table 3). The impact of the
interactions can be calculated by multiplication of the
odds ratios [61]. This means for example emergence
inhibition was 85% at 1 mg ai per m2 when ponds were
clear and had a pH <8, emergence inhibition was reduced
to 79% when the same treatment pond was turbid with a
pH <8 and to 74% when the same treatment pond was
turbid and had a pH ≥8. Similarly for the 5 mg ai per m2
ponds in round one, overall emergence inhibition is 97%
when treatment ponds are clear with pH <8, emergence
inhibition is reduced to 95% when the treatment ponds
are turbid with pH <8 and further reduced to 90% when
the treatment ponds are turbid and with pH ≥8.
Sub-lethal effects
The impact of sub-lethal effects could not be evaluated for
An. arabiensis that emerged from pupae since neither fe-
males from untreated ponds nor females from treated
ponds laid eggs, possibly due to unsuitable mating condi-
tions provided for this species [62]. Exposure of An.
gambiae s.s. to both SumilarvW0.5G dosages during the lar-
val stage resulted in: (i) a reduced probability of the adult
female laying eggs; (ii) reduced mean number of eggs laid
per female; and, (iii) reduced mean number of eggs that
hatched into larvae (Table 4). Treatment rounds were not
significantly different (p=0.687), and data for all rounds for
An. gambiae s.s. were pooled for analysis. Mosquitoes that
emerged from treated ponds were 65-68% less likely to lay
eggs compared to mosquitoes that emerged from untreated
ponds. The mean number of eggs laid per female An.
gambiae s.s. was reduced by 47% from females emerging
from ponds treated at 1 mg ai per m2 and by 74% from fe-
males emerged from ponds treated at 5 mg ai per m2 com-
pared to that in the untreated controls (Table 4). The
impact of the higher dosage was twice the impact measured
from the lower dosage (odds ratio (OR) 2.1, 95% CI 1.2-3.7,
p=0.02). Furthermore, it was 90% less likely for an egg to
hatch that was laid by a female exposed to the higher
SumilarvW0.5G dosage compared to eggs laid by females
that emerged from low dosage ponds (OR=0.10, 95% CI
0.04-0.23, p<0.0001). The probability of an egg hatching
was reduced by 77% for eggs laid by a female exposed to
the lower treatment dosage and 98% for eggs laid by a fe-
male exposed to the higher dosage as compared to eggs in
females that emerged from the untreated control ponds.
Discussion
Anopheles arabiensis and An. gambiae s.s. were equally
and highly susceptible to SumilarvW0.5G under laboratory
Table 1 Estimated doses (ppm ai) of SumilarvW0.5G for
50%, 90% and 99% emergence inhibition (EI) in
Anopheles gambiae s.s. and Anopheles arabiensis
Anopheles arabiensis Anopheles gambiae s.s.
ppm ai ppm ai
EI50 (95%CI) 0.00012 (0.00009-0.00016) 0.00013 (0.00010-0.00017)
EI90 (95%CI) 0.00248 (0.00154-0.00450) 0.00139 (0.00092-0.00232)
EI99 (95%CI) 0.02860 (0.01379-0.07296) 0.00973 (0.00526-0.02159)
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and standardized field conditions. SumilarvW0.5G inhi-
bited over 80% of the total adult emergence over a period
of six weeks at both application dosages. However, weekly
emergence rates increased steadily over the six-week test
period at the lower dosage that corresponded with the
EI99 in the laboratory and weekly emergence inhibition
was frequently lower than the 80% that is recommended
by WHOPES for successful immature control [57]. La-
boratory tests were conducted under standardized condi-
tions without major abiotic and biotic influences and
therefore EI values represent only minimum dosages. Ap-
plication rates frequently have to be increased up to sev-
eral times the minimum dose to obtain sufficient
immature control under field conditions [57,63]. The
higher dosage of 5 mg ai per m2 or 0.09 ppm ai inhibited
well over 80% of adult emergence in all but one test week.
This dosage was 4.5 times the average EI99 in the labora-
tory. Further field tests to establish the optimum dose for
operational control in a variety of different habitats are ne-
cessary but based on the results presented here it is likely
that the optimum dosage lies between the two tested here
and therefore coincides with the maximum dosage
recommended by the manufacturer (0.05 ppm ai) for op-
erational control of other mosquito species [64].
The estimated emergence inhibition rates from the
dose–response tests were four times higher than those
previously reported by Kawada and his colleagues [65] for
An. gambiae, but within the range of rates estimated for
Culex and Aedes species [66-70]. These differences may
arise from the different pyriproxyfen formulations used in
separate studies [71], but also from the material of the test
containers [44]. Kawada and colleagues used a 5% emulsi-
fiable concentrate formulation while in the present study
a granular formulation was used and had to be crushed in
a mortar for the laboratory tests, which might have not
led to an equal amount of active ingredients being re-
leased into the stock solution. Also, in the present study
plastic cups were used for bioassays while Kawada and his
colleagues used aluminium cups. There is a concern that
the active ingredient pyriproxyfen adheres to plastic [72]
leading to a longer residual effect from such treated
containers due to a continuous slow release from the plas-
tic [54]. In the short term however, plastic might reduce
the amount of active ingredient in the water, which could
be responsible for the higher estimates of EI concentra-
tions found in this study. The extremely low concentra-
tions of active ingredient needed for the control of
mosquitoes with SumilarvW0.5G is worth noting. The esti-
mated effective dose of pyriproxyfen is approximately 10
times lower than those reported for microbial larvicides
[20,21]. This is not surprising since pyriproxyfen is a ju-
venile hormone analogue, and insect hormones, like all
hormones, operate at extremely low concentrations as
chemical messengers [70,73]. Thus, far smaller quantities
of SumilarvW0.5G would be required for larviciding
programmes compared to microbial larvicides, thereby
helping to lower costs associated with transporting and
storing larvicides [39].
The residual impact of SumilarvW0.5G on An. gambiae
s.l. emergence observed here corresponds well with re-
ports from previous studies on other mosquito species
[44,67,74] but application dosages required to achieve the
same effect seem slightly higher for An. gambiae s.l.
SumilarvW0.5G at 0.02 ppm ai and 0.05 ppm ai pro-
vided almost complete emergence inhibition of Aedes
aegypti, Aedes albopictus and Aedes taeniorhynchus,
Culex nigripalpus and Anopheles quadrimaculatus for
six weeks under standardized field conditions [74]. This
slow-release formulation has even been shown to exhibit
prolonged residual activity for control of Aedes larvae even
when the treatments were diluted by using replacement of
treated water with untreated water in the treated containers
[44,75]. Similarly, here it was observed that rainfall did not
negatively affect the impact of the treatments. Exceptional
performance of SumilarvW0.5G was reported for the
control of Anopheles culicifacies in confined gem pits in Sri
Lanka [45] where a single application of pyriproxyfen at
0.01 ppm ai was sufficient to inhibit adult emergence for
approximately six months. Similarly, Sihuincha and
colleagues [49] reported complete emergence inhibition of
Ae. aegypti for five months from water tanks in Peru at an
application rate of SumilarvW0.5G of 0.05 ppm ai. Overall
Table 2 Weekly percent emergence inhibition (95% CI) of Anopheles gambiae s.l. from treated ponds
Week 1 Week 2 Week 3 Week 4 Week 5 Week 6
1 mg ai per m2
Round 1 100 98 (94–99) 65 (55–72) 95 (90–98) 93 (85–97) 66 (59–71)
Round 2 88 (83–92) 86 (76–90) 83 (76–88) 78 (69–85) 79 (73–84) 72 (62–80)
Round 3 100 92 (80–97) 94 (86–98) 71 (62–78) 62 (54–69) 57 (47–64)
5 mg ai per m2
Round 1 100 100 94 (80–98) 98 (96–99) 91 (82–95) 84 (73–90)
Round 2 99 (95–100) 95 (81–99) 97 (96–98) 96 (90–99) 97 (94–99) 95 (90–98)
Round 3 100 100 98 (95–99) 85 (79–89) 74 (69–78) 90 (83–94)
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it can be concluded from previous work that the efficacy
and residual activity of different pyriproxyfen-containing
products depends on the formulation, dose, habitat types
treated, prevailing weather conditions and target mosquito
species [53,67,74].
The current study showed that the efficacy of
SumilarvW0.5G is reduced in turbid water and water with
a pH ≥8. Water is turbid because it carries a suspension of
fine particles of both organic and inorganic matter in the
water column. Some of the turbidity observed here might
have been due to algae and bacteria growth in the
established habitats, which in turn might have increased
the water pH. It is possible that the active ingredient,
pyriproxyfen, is adsorbed onto particles in the water col-
umn and was less accessible to larvae. Turbidity and pH
of aquatic habitats are important parameters that are asso-
ciated with the abundance, development and survival of
Anopheles larvae [76]. Anopheles larvae are known to ex-
ploit aquatic habitats with varying degrees of water turbid-
ity and pH [76,77]. Suspended particles including algae in
the water column in turbid ponds provide mosquitoes
with food that enhances their development and survival
thus increase emergence from turbid ponds [78,79]. Mulli-
gan and Schaefer [80] found pyriproxyfen to adsorb onto
organic matter which might have been responsible for lar-
vae to be exposed to reduced doses. This needs to be con-
sidered and monitored in field operations where it might
be necessary to increase the application dose or reduce
retreatment intervals to ensure a consistent emergence in-
hibition above 80% as recommended by WHOPES [57].
An added benefit to the direct effect of SumilarvW0.5G
on immature stages were the sub-lethal effects that af-
fected the offspring of adult females that successfully
emerged from treated ponds. At 5 mg ai per m2 the
reproduction of females was reduced by well over 90%.
Similar effects of insect growth regulators have been
shown for Aedes and Culex [46,47,81]. The laying of non-
viable eggs by female An. gambiae s.s. emerging from
treated ponds might further extend the efficacy and re-
sidual effect of pyriproxyfen, and may help further reduce
intervention costs by extending the retreatment intervals.
It would be particularly helpful in the context of an auto-
dissemination strategy [82] of SumilarvW0.5G where po-
tentially only sub-lethal doses are transferred to a habitat
by female gravid mosquitoes. The delayed sub-lethal ef-
fects of insect growth regulators were also shown to affect
the sex ratio and to reduce blood-feeding rates in exposed
mosquitoes [47,83]. Similar effects were shown for adults
exposed to pyriproxifen [48,49,84]. Ohashi and colleagues
[84] demonstrated that An. gambiae s.s. was completely
sterilized, with no female laying eggs after exposure to
pyriproxyfen-treated nets. Insect growth regulators have
been shown to suppress ovarian development and egg de-
velopment in mosquitoes [85,86]. Judson and de Lumen
[85] showed that exposure of Ae. aegypti females to juven-
ile hormone analogues suppressed egg development by
inhibiting development of ovarian follicles. Fournet and
colleagues [86] similarly showed that the ovarian develop-
ment of Ae. aegypti females that emerged from larvae ex-
posed to insect growth regulators was affected.
As with every insecticide it is important to be cautious
about using pyriproxyfen formulations as a stand-alone
Table 3 Multivariable analyses (GEE) of factors affecting
the emergence of adult malaria vectors over a six week
period from artificial ponds treated with SumilarvW0.5G
Explanatory variable OR 95% CI p
Treatment
1 mg ai per m2 0.03 0.02-0.05 <0.0001
5 mg ai per m2 0.15 0.12-0.18 <0.0001
control 1
Round
round 3 1.19 1.00-1.41 0.050
round 2 1.03 0.78-1.34 0.859
round 1 1
Vector species
An. arabiensis 0.95 0.86-1.05 0.278
An. gambiae s.s. 1
Water turbidity
turbid 1.01 0.95-1.07 0.765
clear 1
Water pH
≥ 8 0.99 0.91-1.08 0.820
< 8 1
Rain during test week
rain 1.05 0.92-1.20 0.449
no rain 1
Interaction between treatment and turbidity
5 mg ai per m2*turbid 1.93 1.12-3.26 0.017
5 mg ai per m2*clear 1
1 mg ai per m2*turbid 1.40 1.08-1.79 0.011
1 mg ai per m2*clear 1
Interaction between treatment and pH
5 mg ai per m2*pH≥8 1.90 1.13-2.85 0.002
5 mg ai per m2*pH<8 1
1 mg ai per m2*pH≥8 1.25 1.06-1.47 0.008
1 mg ai per m2*pH<8 1
Interaction between treatment and rain
5 mg ai per m2*rain 1.23 0.89-1.69 0.211
5 mg ai per m2*no rain 1
1 mg ai per m2*rain 0.87 0.70-1.07 0.870
1 mg ai per m2*no rain 1
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intervention since tolerance to pyriproxyfen has been
found in Diptera [87,88]. It is also of concern to know
whether the progeny of gravid females that are exposed
to sub-lethal level doses of pyriproxyfen and survive
have greater tolerance to pyriproxyfen than other mos-
quitoes. If this is the case, resistance may spread.
Pyriproxyfen exhibits favourable characteristics for
utilization as a larvicide for mosquito control. The
recommended application rate in drinking water limit of
300 ppb (0.3 ppm) [51] is several folds higher than the
recommended dose of 0.01-0.05 ppm [64] for mosquito
control and also has minimal environmental impacts at
recommended rates for mosquitoes [52,53].
Conclusion
Anopheles arabiensis and An. gambiae s.s. are highly sus-
ceptible to SumilarvW0.5G at very low dosages. The per-
sistence of SumilarvW0.5G in treated habitats under
standardized field conditions and its sub-lethal impact, re-
ducing the number of viable eggs from adults emerging
from treated ponds, enhances its potential as a malaria
vector control tool in integrated vector management strat-
egies. These unique properties of SumilarvW0.5G warrant
further field testing in a range of natural An. gambiae s.l.
larval habitats and under operational conditions to recom-
mend if and how this insect growth regulator could be
included in vector control programmes for malaria control
in sub-Saharan Africa.
Based on the results of this study the maximum dos-
age recommended by the manufacturer for other mos-
quito species of 0.05 ppm ai is recommended as the
minimum dosage for further field testing for An.
gambiae s.l control. Although the residual effect ob-
served for the test concentrations lasted for a six-week
period, initially a shorter retreatment interval should be
evaluated under natural conditions where habitat types
and water quality are highly heterogeneous and might
affect the residual activity. Furthermore, the estimation
of retreatment intervals should also consider the prob-
ability of new habitats emerging during treatment cycles
that could then harbour mosquito larvae that might suc-
cessfully emerge before the target area receives another
round of SumilarvW0.5G application. Initial application
cycles should be determined for the predominant habitat
type in the target area, the season of application and the
development time of immature vectors. In areas where
temporary habitats dominate or areas with high rainfall
an initial application cycle of two to three weeks should
be tested whilst in areas of more semi-permanent to
permanent habitats or during dry seasons a three to
four-weekly application cycle might be appropriate for
an initial field operation informed by a monitoring and
evaluation programme.
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Figure 4 Weekly rainfall during the three rounds of standardized field tests.
Table 4 Sub-lethal effects of SumilarvW 0.5G on egg laying and hatching of Anopheles gambiae s.s.
Control 1 mg ai per m2 5 mg ai per m2
Number of females exposed 60 60 30
Number of females that laid eggs 43 27 14
Mean number of eggs/female (95% CI) 43.8 (35.6-53.8) 23.1 (16.5-32.3) 11.2 (6.9-18.2)
Mean number eggs/female hatched (95% CI) 37.4 (30.5-45.8) 8.7 (6.0-12.4) 0.8 (0.4-1.8)
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